Abstract:As a tumor suppressor and the most frequently mutated gene in cancer, p53 is among the best-described molecules in medical research. As cancer is in most cases an age-related disease, it seems paradoxical that p53 is so strongly conserved from early multicellular organisms to humans. A function not directly related to tumor suppression, such as the regulation of metabolism in nontransformed cells, could explain this selective pressure. While this role of p53 in cellular metabolism is gradually emerging, it is imperative to dissect the tissue- and cell-specific actions of p53 and its downstream signaling pathways. In this review, we focus on studies reporting p53's impact on adipocyte development, function, and maintenance, as well as the causes and consequences of altered p53 levels in white and brown adipose tissue (AT) with respect to systemic energy homeostasis. While whole body p53 knockout mice gain less weight and fat mass under a high-fat diet owing to increased energy expenditure, modifying p53 expression specifically in adipocytes yields more refined insights: (1) p53 is a negative regulator of in vitro adipogenesis; (2) p53 levels in white AT are increased in diet-induced and genetic obesity mouse models and in obese humans; (3) functionally, elevated p53 in white AT increases senescence and chronic inflammation, aggravating systemic insulin resistance; (4) p53 is not required for normal development of brown AT; and (5) when p53 is activated in brown AT in mice fed a high-fat diet, it increases brown AT temperature and brown AT marker gene expression, thereby contributing to reduced fat mass accumulation. In addition, p53 is increasingly being recognized as crucial player in nutrient sensing pathways. Hence, despite existence of contradictory findings and a varying density of evidence, several functions of p53 in adipocytes and ATs have been emerging, positioning p53 as an essential regulatory hub in ATs. Future studies need to make use of more sophisticated in vivo model systems and should identify an AT-specific set of p53 target genes and downstream pathways upon different (nutrient) challenges to identify novel therapeutic targets to curb metabolic diseases.

Transcription factor p63, a member of the p53 family of tumour suppressors, regulates hepatic glucose metabolism

The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy

The p53 tumor suppressor regulates AKR1B1 expression, a metastasis-promoting gene in breast cancer

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

P63 in health and cancer

Tumor Suppressor P53 Cooperates with SIRT6 to Regulate Gluconeogenesis by Promoting FoxO1 Nuclear Exclusion.

p53 Functions in Adipose Tissue Metabolism and Homeostasis

P53 Regulates Biosynthesis Through Direct Inactivation of Glucose-6-phosphate Dehydrogenase

p53 regulates lipid metabolism in cancer

P53 and Regulation of Tumor Metabolism

A double dealing tale of p63: an oncogene or a tumor suppressor

Control of p53-dependent transcription and enhancer activity by the p53 family member p63

Overexpression of P53 Improves Blood Glucose Control in an Insulin Resistant Diabetic Mouse Model.

p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment.

p53 in survival, death and metabolic health: a lifeguard with a licence to kill

P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds

Cellular adaptation to hypoxia and p53 transcription regulation

Regulation of Metabolic Activity by p53

Emerging Roles of the Tumor Suppressor p53 in Metabolism

KRAB-type Zinc-Finger Proteins PITA and PISA Specifically Regulate P53-Dependent Glycolysis and Mitochondrial Respiration

Microrna-20a-5p Contributes to Hepatic Glycogen Synthesis Through Targeting P63 to Regulate P53 and Pten Expression